Jones Financial Companies’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.94M Buy
46,534
+15,923
+52% +$1.73M ﹤0.01% 1046
2026
Q1
$2.59M Buy
30,611
+13,232
+76% +$1.33M ﹤0.01% 1318
2025
Q4
$1.78M Buy
17,379
+2,128
+14% +$190K ﹤0.01% 1008
2025
Q3
$916K Buy
15,251
+7,119
+88% +$387K ﹤0.01% 1163
2025
Q2
$414K Buy
8,132
+3,341
+70% +$149K ﹤0.01% 1347
2025
Q1
$207K Buy
4,791
+2,095
+78% +$90.4K ﹤0.01% 1481
2024
Q4
$82.4K Buy
2,696
+817
+43% +$23K ﹤0.01% 1692
2024
Q3
$43K Buy
1,879
+1,281
+214% +$36.3K ﹤0.01% 1699
2024
Q2
$17.3K Buy
598
+55
+10% +$1.28K ﹤0.01% 1582
2024
Q1
$11.2K Buy
+543
New +$11.6K ﹤0.01% 1042

Other funds holding GH

Jones Financial Companies's GH Position: Q2 2026 in Review

Jones Financial Companies increased its Guardant Health (GH) stake by 52% in Q2 2026, buying an estimated $1.73M and bringing the position to 46,534 shares worth $6.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1046.

Jones Financial Companies first reported a position in GH in Q1 2024 and has held it in 10 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Jones Financial Companies held 46,534 shares of Guardant Health worth $6.94M as of Q2 2026.
  • Jones Financial Companies bought 15,923 Guardant Health shares in Q2 2026, an estimated $1.73M.
  • Guardant Health made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1046 holding.
  • Jones Financial Companies first reported a position in Guardant Health in Q1 2024 and has held it in 10 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.